We are live on ! Find out more
CLRBZ

Cellectar Biosciences, Inc. Series A Warrants
CLRBZ

Delisted

CLRBZ was delisted on the 16th of April, 2021.

Back to rankings

2 hedge funds and large institutions have $41K invested in Cellectar Biosciences, Inc. Series A Warrants in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

55% less capital invested

Capital invested by funds: $92K → $41K (-$51K)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$4.23K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
1
CVI Holdings
Delaware
$39K – – –
VF
2
Virtu Financial
New York
$2K +$4.23K +11,892 New
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
– -$5K -12,272 Closed

CLRBZ Hedge Fund Activity: Q2 2018 in Review

2 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) for Q2 2018, worth a combined $41K — down 55% from $92K a quarter earlier.

Fund positioning in CLRBZ was balanced in Q2 2018: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $4.23K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $5K sold.

  • 2 institutional investors held Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $41K of Cellectar Biosciences, Inc. Series A Warrants stock for Q2 2018, down 55% quarter-over-quarter.
  • 1 fund opened new Cellectar Biosciences, Inc. Series A Warrants positions in Q2 2018 and 1 closed out, a net change of 0 holders.
  • The largest Cellectar Biosciences, Inc. Series A Warrants buyer in Q2 2018 was Virtu Financial, an estimated $4.23K added.
  • The largest Cellectar Biosciences, Inc. Series A Warrants seller in Q2 2018 was Susquehanna International Group, an estimated $5K sold.

Based on aggregated 13F filings for Q2 2018.